Safety and Efficacy of the Fixed-Dose Combination Regimen of MK-3682/Grazoprevir/MK-8408 With or Without Ribavirin in Non-cirrhotic or Cirrhotic Patients with Chronic HCV GT1, 2 or 3 Infection (Part B of C-CREST-1 & 2)Eric Lawitz,Eric M. Yoshida, Maria Buti,John M. Vierling,Piero L. Almasio,Savino Bruno,Peter J. Ruane,Tarek I. Hassanein,Jacob P. Lalezari,Beat Mullhaupt,Brian Pearlman,Wei Gao,Hsueh-cheng Huang,Aimee Shepherd,Brynne Tannenbaum, Doreen Fernsler,Jerry J. Li,Anjana Grandhi,Shuyan Wan,Frank Dutko,Wendy W. Yeh,Rebeca Plank,Bach-Yen T. Nguyen,Janice Wahl,Eliav Barr,Joan R. ButtertonHEPATOLOGY（2016）引用 0|浏览25暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
